Literature DB >> 20131266

Epidemiology of gout in women: Fifty-two-year followup of a prospective cohort.

Vidula Bhole1, Mary de Vera, M Mushfiqur Rahman, Eswar Krishnan, Hyon Choi.   

Abstract

OBJECTIVE: Despite the recent doubling of the incidence of gout among women and its substantial prevalence particularly in the aging female population, the risk factors for gout among women remain unknown. We undertook this study to evaluate purported risk factors for incident gout among women and to compare them with those among men.
METHODS: Using prospective data from the Framingham Heart Study, we examined over a 52-year period (1950-2002) the relationship between purported risk factors and the incidence of gout in 2,476 women and 1,951 men.
RESULTS: We documented 304 incident cases of gout, 104 of them among women. The incidence rates of gout for women per 1,000 person-years according to serum uric acid levels of <5.0, 5.0-5.9, 6.0-6.9, 7.0-7.9, and > or = 8.0 mg/dl were 0.8, 2.5, 4.2, 13.1, and 27.3, respectively (P for trend < 0.0001). The magnitude of this association was lower than that among men (P for interaction = 0.0002). Multivariate relative risks conferred by increasing age (per 5 years), obesity (body mass index > or = 30 kg/m(2)), alcohol intake (> or = 7 ounces of pure alcohol/week), hypertension, and diuretic use were 1.24, 2.74, 3.10, 1.82, and 2.39, respectively (all P < 0.05), for women.
CONCLUSION: These prospective data with long-term followup provide evidence that higher levels of serum uric acid increase the risk of gout in a graded manner among women, but the rate of increase is lower than that among men. Increasing age, obesity, alcohol consumption, hypertension, and diuretic use were associated with the risk of incident gout among women.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20131266     DOI: 10.1002/art.27338

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  63 in total

1.  Oral colchicine (colcrys®) in the treatment and prophylaxis of gout†: profile report.

Authors:  Lily P H Yang
Journal:  Drugs Aging       Date:  2010-10-01       Impact factor: 3.923

Review 2.  The epidemiology of uric acid and fructose.

Authors:  Young Hee Rho; Yanyan Zhu; Hyon K Choi
Journal:  Semin Nephrol       Date:  2011-09       Impact factor: 5.299

Review 3.  Risk factors for gout and prevention: a systematic review of the literature.

Authors:  Jasvinder A Singh; Supriya G Reddy; Joseph Kundukulam
Journal:  Curr Opin Rheumatol       Date:  2011-03       Impact factor: 5.006

4.  The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012.

Authors:  Sharan K Rai; J Antonio Aviña-Zubieta; Natalie McCormick; Mary A De Vera; Kam Shojania; Eric C Sayre; Hyon K Choi
Journal:  Semin Arthritis Rheum       Date:  2016-08-17       Impact factor: 5.532

Review 5.  Global epidemiology of gout: prevalence, incidence and risk factors.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Weiya Zhang; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2015-07-07       Impact factor: 20.543

Review 6.  Determinants of the prevalence of gout in the general population: a systematic review and meta-regression.

Authors:  José M A Wijnands; Wolfgang Viechtbauer; Kristof Thevissen; Ilja C W Arts; Pieter C Dagnelie; Coen D A Stehouwer; Sjef van der Linden; Annelies Boonen
Journal:  Eur J Epidemiol       Date:  2014-07-27       Impact factor: 8.082

Review 7.  Meat consumption and gout: Friend, foe or neither?

Authors:  Giuseppe Lippi; Camilla Mattiuzzi; Gianfranco Cervellin
Journal:  Rheumatol Int       Date:  2015-03-21       Impact factor: 2.631

8.  Socioeconomic differences in hyperuricemia and gout: a systematic review and meta-analysis.

Authors:  Zhe Pan; Mingkai Huang; Ming Fang; Xu Xie; Ze Huang
Journal:  Endocrine       Date:  2020-04-13       Impact factor: 3.633

9.  Use of electronic recruitment methods in a clinical trial of adults with gout.

Authors:  Hailey N Miller; Jeanne Charleston; Beiwen Wu; Kelly Gleason; Karen White; Cheryl R Dennison Himmelfarb; Daniel E Ford; Timothy B Plante; Allan C Gelber; Lawrence J Appel; Edgar R Miller; Stephen P Juraschek
Journal:  Clin Trials       Date:  2020-09-15       Impact factor: 2.486

10.  The benchmark dose estimation of reference levels of serum urate for gout.

Authors:  Xiao Chen; Zhongqiu Wang; Na Duan; Wenjing Cui; Xiaoqiang Ding; Taiyi Jin
Journal:  Clin Rheumatol       Date:  2018-08-25       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.